je.st
news
Tag: bio
Dr. Jennifer Holmgren to receive BIO award.
2015-07-16 14:31:10| Industrial Newsroom - All News for Today
During 2015 World Congress on Industrial Biotechnology, Dr. Jennifer Holmgren, CEO of carbon recycling company LanzaTech, will deliver remarks and will be presented with inaugural Rosalind Franklin Award. Award honors an outstanding woman in the field of industrial biotechnology and bioprocessing. Under Dr. Holmgren’s guidance, LanzaTech is developing world’s first alternative jet fuel from industrial waste gases using intermediates derived through industrial biotechnology.
Tags: receive
award
bio
jennifer
LanzaTech and Renmatix receive BIO awards.
2015-07-16 14:31:10| Industrial Newsroom - All News for Today
LanzaTech and Renmatix received awards in the Presidential Green Chemistry Challenge for industrial biotechnology applications that produce carbon negative renewable chemicals and fuels. LanzaTech is being recognized for developing process that uses waste gas to produce fuels and chemicals, while Renmatix is being recognized for developing a process using supercritical water to more cost effectively break down plant material into sugars used as building blocks for renewable chemicals and fuels.
Tags: receive
awards
bio
lanzatech
BIO praises House passage of 21st Century Cures legislation.
2015-07-15 14:31:10| Industrial Newsroom - All News for Today
In statement, Jim Greenwood, BIO's President and CEO praised the House of Representatives for vote to pass 21st Century Cures legislation that recognizes critical link between research, development, and reimbursement to expedite delivery of breakthrough treatments and cures to patients suffering from life-threatening and debilitating diseases. According to Greenwood, bill represents forward-looking public policies that sustain scientific discovery and promote biomedical advancement.
Tags: house
century
bio
legislation
BIO opposes Brat amendment regarding NIH funding.
2015-07-13 14:31:07| Industrial Newsroom - All News for Today
BIO issued statement regarding an amendment to the 21st Century Cures Initiative legislation filed by Rep. Dave Brat (R-VA) that would convert mandatory funding for the National Institutes of Health to discretionary spending. According to Jim Greenwood, BIO President and CEO, BIO supports provisions in 21st Century Cures to provide mandatory funding for nation’s biomedical research enterprise by supporting consistent and dependable growth in NIH funding.
Tags: bio
funding
amendment
nih
BIO announces BIO World Congress workshop schedule.
2015-07-13 14:31:07| Industrial Newsroom - All News for Today
Taking place July 19–22, 2015 World Congress on Industrial Biotechnology will include workshops designed for focused discussions on newest trends in business strategies, investment opportunities, and technology development. Topic examples include: Bioproduct Supply Chains in Action; Practical Magic: Genomics, Phenomics and the Next Generation of Advanced Materials; Value of Biobased in a Period of Low Oil Prices; and Protecting Valuable IP in the Face of New Challenges to Patent Eligibility.
Tags: world
schedule
bio
workshop
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »